Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Repeat Nasal Allergen Challenge

This study has been completed.
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00290368
First received: February 10, 2006
Last updated: October 21, 2015
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given